Following these in vitro experiments, we showed a trend towards S1P infusion reducing the in vivo drop in laser Doppler flowmetry signal caused by CA4P treatment alone.
← all excerpts
The protective role of sphingosine-1-phosphate against the action of the vascular disrupting agent combretastatin A-4 3-<i>O</i>-phosphate.
1
—
—